These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5994826)

  • 1. [Experience with high dosage cytostatic "high single dose" therapy of malignant tumors].
    Zerna M; Wolff H
    Bruns Beitr Klin Chir (1971); 1966 Mar; 212(2):146-53. PubMed ID: 5994826
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of very high cyclophosphamide dosage in 42 patients with solid and lymphoreticular tumors].
    Schubert JC; Ischer M; Hilbert L
    Dtsch Med Wochenschr; 1969 Dec; 94(50):2583-8 passim. PubMed ID: 4187888
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytostatic agents and changes in the blood picture].
    Kliment V; Stefanovic J; Deák E; Ziak F; Podhorská O
    Bratisl Lek Listy; 1969 Jul; 52(1):63-6. PubMed ID: 5806836
    [No Abstract]   [Full Text] [Related]  

  • 4. [On clinical use of high single doses of sarcolysine and exdoxan (cyclophosphan)].
    Garin AM; Astrakhan VI; Bychkov MB; Larionov LF; Perevodchikova NI
    Vopr Onkol; 1965; 11(10):3-9. PubMed ID: 5333877
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclophosphamide regimens in rhesus monkey with and without marrow infusion.
    Storb R; Buckner CD; Dillingham LA; Thomas ED
    Cancer Res; 1970 Aug; 30(8):2195-203. PubMed ID: 4990004
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results with cyclophosphamide therapy in single and massive dosage].
    Helbig W; Mühl H
    Z Gesamte Inn Med; 1967 Dec; 22(24):811-4. PubMed ID: 5585478
    [No Abstract]   [Full Text] [Related]  

  • 7. [The use of high-dose cyclophosphamide in the treatment of human solid tumors].
    Meeus-Bith L; Clavel B; Gazeau JN; Bourdin JS
    Sem Hop; 1968 Dec; 44(53):3307-20. PubMed ID: 4307497
    [No Abstract]   [Full Text] [Related]  

  • 8. [High-dosage cytostatic therapy and autologous bone marrow reinfusion in malignant tumors. Current experience of the Viennese workshop on chemotherapy of malignant tumors].
    Mannheimer E; Karrer K; Boeckl O; Priesching A
    Munch Med Wochenschr; 1967 Sep; 109(35):1808-13. PubMed ID: 5240395
    [No Abstract]   [Full Text] [Related]  

  • 9. Hematopoietic recovery after a single high dose of cyclophosphamide in the mouse.
    Scaro JL; Barrio Rendo ME; Alvarez Prado de AR
    Acta Physiol Lat Am; 1972; 22(4):258-65. PubMed ID: 4664105
    [No Abstract]   [Full Text] [Related]  

  • 10. [The state of hemopoiesis in the regional perfusion of malignant tumors of the extremities with sarcolysin, thio-TEPA and cyclophosphane].
    Levin AO; Babinina VF
    Vopr Onkol; 1967; 13(2):48-54. PubMed ID: 4971006
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of nandrolone phenylpropionate (Durabolin) on the bone-marrow suppression caused by cyclophosphamide.
    Cooke WM; Burn JI
    Br J Surg; 1971 Apr; 58(4):302-3. PubMed ID: 4929363
    [No Abstract]   [Full Text] [Related]  

  • 12. Short-term administration of cytembena and cyclophosphamide to patients with gynaecological carcinoma. (Evaluation ff laboratory examinations).
    Jandová A; Skoda V; Novotná J; Pezlarová I; Pick P
    Neoplasma; 1971; 18(2):197-218. PubMed ID: 5280733
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the problem of intraoperative cytostatic high dosage therapy in the treatment of cancer. I].
    Kirsch R; Schmidt D; Fichler J
    Zentralbl Chir; 1967 Sep; 92(38):2559-70 contd. PubMed ID: 5595511
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytostatic chemotherapy in the treatment of malignant tumors].
    Langhammer H; Klemm J; Pabst HW
    Arztl Forsch; 1966 Aug; 20(8):393-403. PubMed ID: 6014703
    [No Abstract]   [Full Text] [Related]  

  • 15. Adriamycin (NSC-123127) in combination with cyclophosphamide (NSC-26271): a phase I and II evaluation.
    Muggia FM; Perloff M; Chia GA; Reed LJ; Escher GC
    Cancer Chemother Rep; 1974; 58(6):919-26. PubMed ID: 4614899
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunologic studies in the lymphocyte culture after high voltage radiotherapy or high-dosage cytostatic therapy and bone marrow transplantation].
    Stinner G; zur Horst-Meyer H
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:116-7. PubMed ID: 4990188
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recovery from cyclophosphamide-induced myelosuppression accelerated by bestatin].
    Uchida K; Kohi F; Yorimitsu S; Takahashi I; Kitajima K; Kimura I
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):220-4. PubMed ID: 7184398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Massive cytostatic therapy after orthovoltage therapy].
    Schawow A
    Radiobiol Radiother (Berl); 1970; 11(6):655-9. PubMed ID: 5509232
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in marrow myelopoietic and lymphoid cell counts after repeated cyclophosphamide administration in the rat.
    Berger J
    Haematologia (Budap); 1981 Dec; 14(4):407-16. PubMed ID: 7344975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Administration of phytohemagglutinin with cytostatic therapy].
    Eggerth G; Kühböck J; Pokorny D
    Wien Z Inn Med; 1969; 50(12):587-92. PubMed ID: 5385163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.